Callan Family Office LLC Buys Shares of 20,031 Danaher Corporation $DHR

Key Points

• Callan Family Office initiated a position of 20,031 Danaher shares valued at approximately $3.815 million. Institutional investors collectively own 79.05% of the company.
• Analyst sentiment remains favorable, with a consensus “Moderate Buy” rating and an average price target of $228.91; recent targets range from $200 to $230.
• Danaher exceeded quarterly expectations, reporting $1.94 in EPS and $6.26 billion in revenue, while revenue increased 5.5% year over year.

Callan Family Office LLC purchased a new position in shares of Danaher Corporation (NYSE:DHR - Free Report) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 20,031 shares of the conglomerate's stock, valued at approximately $3,815,000.

Other institutional investors and hedge funds also recently modified their holdings of the company. High Note Wealth LLC raised its stake in shares of Danaher by 19.2% during the fourth quarter. High Note Wealth LLC now owns 292 shares of the conglomerate's stock valued at $67,000 after purchasing an additional 47 shares in the last quarter. First Command Advisory Services Inc. grew its position in Danaher by 4.4% in the 4th quarter. First Command Advisory Services Inc. now owns 1,104 shares of the conglomerate's stock valued at $253,000 after buying an additional 47 shares in the last quarter. GW&K Investment Management LLC grew its position in Danaher by 8.4% in the 4th quarter. GW&K Investment Management LLC now owns 605 shares of the conglomerate's stock valued at $138,000 after buying an additional 47 shares in the last quarter. Kestra Private Wealth Services LLC increased its stake in Danaher by 0.3% during the 3rd quarter. Kestra Private Wealth Services LLC now owns 15,421 shares of the conglomerate's stock valued at $3,057,000 after buying an additional 48 shares during the period. Finally, SOL Capital Management CO increased its stake in Danaher by 2.7% during the 4th quarter. SOL Capital Management CO now owns 1,879 shares of the conglomerate's stock valued at $430,000 after buying an additional 50 shares during the period. Institutional investors own 79.05% of the company's stock.

Analyst Upgrades and Downgrades

DHR has been the subject of a number of research analyst reports. Weiss Ratings raised shares of Danaher from a "sell (d+)" rating to a "hold (c-)" rating in a research note on Wednesday, July 15th. Wall Street Zen lowered shares of Danaher from a "buy" rating to a "hold" rating in a research note on Saturday, April 25th. Piper Sandler started coverage on Danaher in a report on Thursday, June 11th. They set a "neutral" rating and a $200.00 target price on the stock. Royal Bank Of Canada upped their target price on Danaher from $200.00 to $215.00 and gave the stock an "outperform" rating in a research report on Wednesday, July 22nd. Finally, Evercore reaffirmed an "outperform" rating and set a $230.00 price target on shares of Danaher in a research note on Monday, July 6th. One investment analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $228.91.

Danaher Stock Performance

Shares of DHR opened at $219.42 on Friday. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. The firm's 50 day moving average is $195.80 and its 200-day moving average is $192.61. Danaher Corporation has a 12-month low of $160.93 and a 12-month high of $242.80. The stock has a market capitalization of $154.25 billion, a P/E ratio of 38.97, a P/E/G ratio of 2.72 and a beta of 0.78.

Danaher (NYSE:DHR - Get Free Report) last released its earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, beating the consensus estimate of $1.85 by $0.09. The business had revenue of $6.26 billion during the quarter, compared to analyst estimates of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The business's quarterly revenue was up 5.5% on a year-over-year basis. During the same period in the prior year, the business earned $0.77 earnings per share. Equities research analysts anticipate that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Danaher Profile

Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source